<DOC>
	<DOCNO>NCT02333448</DOCNO>
	<brief_summary>The study consist take 4 tubes blood different time period 10 day , via catheter ( central venous arterial catheter ) already place usual therapeutic management . These sample make possible measure blood level certain marker specific invasive candidiasis . PCR use quantify fungal load precisely , say quantity yeast present blood monitor quantity time . These sample transfer specialized unit store maximum three year use end study .</brief_summary>
	<brief_title>Evaluate Performance Genetic Amplification Polymerase Chain Reaction ( PCR ) `` Mannan Antigenemia Antimannan Antibodies Couple Means Diagnosis Marker Follow-up Invasive Candidiasis .</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Patient inform study patient age least 18 year admit medical Intensive Care Patients suspect invasive candidiasis say : Presenting persistent sepsis despite broadspectrum antibiotherapy least 48 hour target antibiotherapy document bacterial infection ( sepsis define accord : usual SIRS criterion , least 2 follow 4 : temperature &gt; 38°C &lt; 36°C , tachycardia &gt; 90/min , respiratory rate &gt; 20/min blood pressure carbon dioxide ( PaCO2 ) &lt; 32 mmHg , leukocytosis &gt; 12000/mm3 &lt; 4000/mm3 &gt; 10 % immature form . Persistent hemodynamic instability ( impossibility significantly diminish catecholamine requirement , need rapid vascular resuscitation &gt; 1000 ml previous 24 hour ) Candida score ≥ 3 multifocal colonization Decision initiate echinocandin therapy make clinician charge patient Treatment echinocandin &gt; 1 day week precede inclusion Surgical patient : abdominal digestive surgery month precede inclusion Patients cover national health insurance Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>